- Company : Jinan Jianfeng Chemical Co., Ltd.
- Region : Shandong , China
- Category : Apparel & Clothing > Wedding Apparel
- Contact Person : Mr. Vid|||sales
- Telephone :
- Fax :
- Mobile phone :
- Website : www.pharmachemm.com
- Email : [email protected]
- Update : Aug/14/2018
Product Details
Chemical Name: N-(4-(2-aminoacetyl)-5-methoxy-2-phenoxyphenyl)methanesulfonamide hydrochloride Molecular Formula: C16H19ClN2O5S Formula Weight: 386.85 CAS No.: 149436-41-9 Chemical Name: MethanesulfonaMide, N-[4-[2-(forMylaMino)acetyl]-5-hydroxy-2-phenoxyphenyl]- Molecular Formula: C17H18N2O6S Formula Weight: 378.39962 CAS No.: 149457-03-4 Chemical Name: Iguratimod Molecular Formula: C17H14N2O6S Formula Weight: 374.37 CAS No.: 123663-49-0 Iguratimod is an anti-inflammatory small molecule drug used for the treatment of rheumatoid arthritis, together with methotrexate in Japan and China. As of 2015 the biological target was not known, but it prevents NF-?B activation and subsequently selectively inhibits COX-2 and several inflammatory cytokines. Iguratimod is under investigation in Rheumatoid Arthritis. Iguratimod, a methanesulfonanilide, is a novel disease-modifying antirheumatic drug that has been developed exclusively in Japan and China. It inhibits the production of immunoglobulins and various inflammatory cytokines (interleukin-1, -6 and -8 and TNF), and exerts anabolic effects on bone metabolism by stimulating osteoblastic differentiation and inhibiting osteoclastogenesis. On the molecular level, it inhibits the nuclear transcription factor NF-?B but not its inhibitor, I?B?. In addition to these immunomodulatory and other long-lasting effects, iguratimod inhibits cyclooxygenase-2, which provides a synergistic short-term action against pain and inflammation. Efficacy and tolerability are comparable to salazosulfapyridine, and probably also to methotrexate. Combination with methotrexate is synergistic in patients with insufficient response to methotrexate and does not significantly increase adverse events. Liver enzyme elevations and thrombocytopenia are the most significant side effects to watch for. In summary, iguratimod is a welcome addition to the small-mol
